Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chloroxazone hydroxylation in humans

被引:53
作者
Gebhardt, AC
Lucas, D
Menez, JF
Seitz, HK
机构
[1] SALEM MED CTR, LAB ALCOHOL RES LIVER DIS & NUTR, DEPT MED, D-69121 HEIDELBERG, GERMANY
[2] FAC MED BREST, EQUIPE ACCUEIL DIRECT RECH ETUD DOCTORALE, EQUIPE ACCUEIL 948, LAB BIOCHIM NUTR, BREST, BELARUS
关键词
D O I
10.1002/hep.510260423
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chlormethiazole is a sedative and anticonvulsive drug used in the treatment of alcohol withdrawal. Because it had been reported that chlormethiazole inhibits the alcohol-inducible cytochrome P450 2E1 in rat liver, we investigated the in vivo and in vitro effect of this drug on cytochrome P450 2E1 in human beings, The activity of this cytochrome was assessed using chlorzoxazone as a probe. The 6-hydroxychlorzoxazone-chlorzoxazone blood concentration ratio, reflecting the cytochrome P450 2E1 activity, was determined in 10 controls and in 24 alcoholic patients who had entered a hospital for detoxification. Alcoholic patients were administered either chlormethiazole (1.3-2.3 g/d) or chlorazepate (100-300 mg/d) as a sedative. Cytochrome P450 2E1 activity was significantly increased in alcoholic patients treated with chlorazepate (1.16 +/- 0.40 vs. 0.27 +/- 0.03, P <.05). In contrast, chlormethiazole treatment inhibited chlorzoxazone hydroxylation almost totally (0.046 +/- 0.03, P <.001), After 7-14 days of ethanol withdrawal, alcoholic patients treated with chlorazepate had ratio values similar to those of controls (0.31 +/- 0.05), whereas values from alcoholic patients treated with chlormethiazole remained low (0.049 +/- 0.01) even though chlormethiazole doses were gradually decreased. Pharmacokinetic studies in controls showed that chlormethiazole-mediated inhibition was present even when chlormethiazole was not detectable in the blood. in addition, the effect of chlormethiazole on cytochrome P450 2E1 was studied in vitro using human liver microsomes, Dixon plot analyses showed a noncompetitive inhibition (Ki = 12 mu mol/L). These data clearly show that chlormethiazole is an efficient inhibitor of chlorzoxazone metabolism and thus of cytochrome P450 2E1 activity in human beings. Because cytochrome P450 2E1 induction after chronic ethanol consumption has detrimental effects on the liver through free radical formation, treatment of alcohol detoxification with chlormethiazole may be beneficial.
引用
收藏
页码:957 / 961
页数:5
相关论文
共 37 条
[1]   Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol [J].
Albano, E ;
Clot, P ;
Morimoto, M ;
Tomasi, A ;
IngelmanSundberg, M ;
French, SW .
HEPATOLOGY, 1996, 23 (01) :155-163
[2]   Chlorzoxazone as a single sample probe of hepatis CYP2E1 activity in humans [J].
Bachmann, K ;
Sarver, JG .
PHARMACOLOGY, 1996, 52 (03) :169-177
[3]   INHIBITION OF CYP2E1 ACTIVITY DOES NOT ABOLISH PULSATILE URINE ALCOHOL CONCENTRATIONS DURING CHRONIC ALCOHOL INFUSIONS [J].
BADGER, TM ;
RONIS, MJJ ;
INGELMANSUNDBERG, M ;
HAKKAK, R .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 230 (03) :914-919
[4]   MODULATION OF RAT HEPATIC-MICROSOMAL MONOOXYGENASE ENZYMES AND CYTOTOXICITY BY DIALLYL SULFIDE [J].
BRADY, JF ;
WANG, MH ;
HONG, JY ;
XIAO, F ;
LI, Y ;
YOO, JSH ;
NING, SM ;
LEE, MJ ;
FUKUTO, JM ;
GAPAC, JM ;
YANG, CS .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 108 (02) :342-354
[5]   EFFECTS OF DISULFIRAM ON HEPATIC P450IIE1, OTHER MICROSOMAL-ENZYMES, AND HEPATOTOXICITY IN RATS [J].
BRADY, JF ;
XIAO, F ;
WANG, MH ;
LI, Y ;
NING, SM ;
GAPAC, JM ;
YANG, CS .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 108 (02) :366-373
[6]   THE ROLE OF INDIVIDUAL HUMAN CYTOCHROMES-P450 IN DRUG-METABOLISM AND CLINICAL-RESPONSE [J].
CHOLERTON, S ;
DALY, AK ;
IDLE, JR .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (12) :434-439
[7]  
FRENCH SW, 1992, HEPATOLOGY, V16, P534
[8]  
GARRO AJ, 1981, CANCER RES, V41, P120
[9]   ASSESSMENT OF CYTOCHROME P4502E1 INDUCTION IN ALCOHOLIC PATIENTS BY CHLORZOXAZONE PHARMACOKINETICS [J].
GIRRE, C ;
LUCAS, D ;
HISPARD, E ;
MENEZ, C ;
DALLY, S ;
MENEZ, JF .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (09) :1503-1508
[10]   Characterization of inducible nitric-oxide synthase by cytochrome P-450 substrates and inhibitors - Inhibition by chlorzoxazone [J].
Grant, SK ;
Green, BG ;
Wang, R ;
Pacholok, SG ;
Kozarich, JW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) :977-983